53 related articles for article (PubMed ID: 7383109)
1. Importance of left ventricular chamber size in determining the response to hydralazine in severe chronic heart failure.
Packer M; Meller J; Medina N; Gorlin R; Herman MV
N Engl J Med; 1980 Jul; 303(5):250-5. PubMed ID: 7383109
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure.
Packer M; Meller J; Medina N; Yushak M; Gorlin R
N Engl J Med; 1982 Jan; 306(2):57-62. PubMed ID: 7053487
[TBL] [Abstract][Full Text] [Related]
3. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
4. Hydralazine pharmacodynamics in the dog.
Kittleson MD; Hamlin RL
Am J Vet Res; 1983 Aug; 44(8):1501-5. PubMed ID: 6625299
[TBL] [Abstract][Full Text] [Related]
5. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure.
Gavazzi A; Berzuini C; Campana C; Inserra C; Ponzetta M; Sebastiani R; Ghio S; Recusani F
J Heart Lung Transplant; 1997 Jul; 16(7):774-85. PubMed ID: 9257260
[TBL] [Abstract][Full Text] [Related]
6. [Regional left ventricular function in dilated cardiomyopathy: observation of regional left ventricular wall motion before and during dobutamine administration].
Kubo M; Yokota Y; Takarada A; Kumaki T; Seo T; Maehashi N; Toh S; Hayakawa M; Inoh T; Fukuzaki H
J Cardiogr; 1985 Jun; 15(2):387-98. PubMed ID: 4093622
[TBL] [Abstract][Full Text] [Related]
7. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of intravenous hydralazine in pregnant women with severe hypertension.
Kuzniar J; Skret A; Piela A; Szmigiel Z; Zaczek T
Obstet Gynecol; 1985 Oct; 66(4):453-8. PubMed ID: 4047535
[TBL] [Abstract][Full Text] [Related]
9. [Short- and long-term effects of enalapril on the left ventricular function in patients with congestive heart insufficiency].
Traina M; Rotolo A; Trapani R; Messina L; Candela B; Mercurio G; Raineri A
Cardiologia; 1990 Jan; 35(1):55-60. PubMed ID: 2376053
[TBL] [Abstract][Full Text] [Related]
10. Determinants of circulatory response to intravenous hydralazine in congestive heart failure.
Wilson JR; St John Sutton M; Schwartz JS; Ferraro N; Reichek N
Am J Cardiol; 1983 Aug; 52(3):299-303. PubMed ID: 6869277
[TBL] [Abstract][Full Text] [Related]
11. Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure.
Rubin SA; Chatterjee K; Ports TA; Gelberg HJ; Brundage BH; Parmley WW
Am J Cardiol; 1979 Nov; 44(6):1183-9. PubMed ID: 495513
[TBL] [Abstract][Full Text] [Related]
12. Increased ionized calcium and left ventricular contractility during hemodialysis.
Henrich WL; Hunt JM; Nixon JV
N Engl J Med; 1984 Jan; 310(1):19-23. PubMed ID: 6689735
[TBL] [Abstract][Full Text] [Related]
13. The effects of oral hydralazine on right ventricular end-diastolic pressure in patients with right ventricular failure.
Rubin LJ; Handel F; Peter RH
Circulation; 1982 Jun; 65(7):1369-73. PubMed ID: 7074795
[TBL] [Abstract][Full Text] [Related]
14. Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.
Chatterjee K; Ports TA; Arnold S; Brundage B; Parmley W
Br Heart J; 1979 Dec; 42(6):657-63. PubMed ID: 534582
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive assessment of left ventricular effects of hydralazine in heart failure.
Deglin SM; Jain AC; Harris WS
Cardiology; 1980; 66(4):193-8. PubMed ID: 7448835
[TBL] [Abstract][Full Text] [Related]
16. Acute and chronic effects of oral hydralazine on left ventricular pump function and renal hemodynamics in chronic left heart failure.
Mathey D; Hanrath P; Polster J; Witte G; Montz R; Bleifeld W
Eur Heart J; 1980 Feb; 1(1):25-9. PubMed ID: 7285964
[No Abstract] [Full Text] [Related]
17. Outflow resistance as a regulator of left ventricular performance.
Franciosa JA
Angiology; 1978 May; 29(5):393-401. PubMed ID: 655470
[No Abstract] [Full Text] [Related]
18. Central hemodynamic effects of dipyridamole in severe heart failure: comparison with hydralazine.
Packer M; Gorlin R; Meller J; Medina N
Clin Pharmacol Ther; 1982 Jul; 32(1):54-61. PubMed ID: 7083730
[TBL] [Abstract][Full Text] [Related]
19. Hydralazine in the management of left ventricular failure.
Fitchett DH; Neto JA; Oakley CM; Goodwin JF
Am J Cardiol; 1979 Aug; 44(2):303-9. PubMed ID: 463768
[No Abstract] [Full Text] [Related]
20. Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo.
Franciosa JA; Weber KT; Levine TB; Kinasewitz GT; Janicki JS; West J; Henis MM; Cohn JN
Am Heart J; 1982 Sep; 104(3):587-94. PubMed ID: 7051796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
